| Pathophysiological role of host microbiota in the development of obesity N Kobyliak, O Virchenko, T Falalyeyeva Nutrition journal 15, 1-12, 2015 | 179 | 2015 |
| Effect of alive probiotic on insulin resistance in type 2 diabetes patients: randomized clinical trial N Kobyliak, T Falalyeyeva, G Mykhalchyshyn, D Kyriienko, ... Diabetes & Metabolic Syndrome: Clinical Research & Reviews 12 (5), 617-624, 2018 | 178 | 2018 |
| Treatment efficacy of a probiotic preparation for non‐alcoholic steatohepatitis: a pilot trial E Manzhalii, O Virchenko, T Falalyeyeva, T Beregova, W Stremmel Journal of digestive diseases 18 (12), 698-703, 2017 | 102 | 2017 |
| Beneficial effects of probiotic combination with omega-3 fatty acids in NAFLD: a randomized clinical study N Kobyliak, L Abenavoli, T Falalyeyeva, G Mykhalchyshyn, L Boccuto, ... | 88 | 2018 |
| Obeticholic acid: a new era in the treatment of nonalcoholic fatty liver disease L Abenavoli, T Falalyeyeva, L Boccuto, O Tsyryuk, N Kobyliak Pharmaceuticals 11 (4), 104, 2018 | 79 | 2018 |
| The efficacy of probiotics for monosodium glutamate-induced obesity: dietology concerns and opportunities for prevention OA Savcheniuk, OV Virchenko, TM Falalyeyeva, TV Beregova, ... EPMA Journal 5, 1-17, 2014 | 78 | 2014 |
| Crosstalk between gut microbiota and antidiabetic drug action Y Kyriachenko, T Falalyeyeva, O Korotkyi, N Molochek, N Kobyliak World journal of diabetes 10 (3), 154, 2019 | 73 | 2019 |
| Short-term periodic consumption of multiprobiotic from childhood improves insulin sensitivity, prevents development of non-alcoholic fatty liver disease and adiposity in adult … O Savcheniuk, N Kobyliak, M Kondro, O Virchenko, T Falalyeyeva, ... BMC complementary and alternative medicine 14, 1-17, 2014 | 71 | 2014 |
| Antioxidative effects of cerium dioxide nanoparticles ameliorate age-related male infertility: optimistic results in rats and the review of clinical clues for integrative … NM Kobyliak, TM Falalyeyeva, OG Kuryk, TV Beregova, PM Bodnar, ... EPMA Journal 6, 1-22, 2015 | 68 | 2015 |
| Cerium dioxide nanoparticles possess anti-inflammatory properties in the conditions of the obesity-associated NAFLD in rats N Kobyliak, O Virchenko, T Falalyeyeva, M Kondro, T Beregova, P Bodnar, ... Biomedicine & Pharmacotherapy 90, 608-614, 2017 | 67 | 2017 |
| Probiotics and nutraceuticals as a new frontier in obesity prevention and management N Kobyliak, T Falalyeyeva, N Boyko, O Tsyryuk, T Beregova, ... Diabetes research and clinical practice 141, 190-199, 2018 | 60 | 2018 |
| Probiotics supplemented with omega-3 fatty acids are more effective for hepatic steatosis reduction in an animal model of obesity N Kobyliak, T Falalyeyeva, P Bodnar, T Beregova Probiotics and Antimicrobial Proteins 9, 123-130, 2017 | 46 | 2017 |
| Efficacy of probiotics and smectite in rats with non-alcoholic fatty liver disease N Kobyliak, L Abenavoli, T Falalyeyeva, T Beregova Annals of hepatology 17 (1), 153-161, 2018 | 41 | 2018 |
| Prevention of NAFLD development in rats with obesity via the improvement of pro/antioxidant state by cerium dioxide nanoparticles N Kobyliak, L Abenavoli, T Falalyeyeva, O Virchenko, B Natalia, ... Clujul Medical 89 (2), 229, 2016 | 41 | 2016 |
| Probiotic and omega-3 polyunsaturated fatty acids supplementation reduces insulin resistance, improves glycemia and obesity parameters in individuals with type 2 diabetes: A … N Kobyliak, T Falalyeyeva, G Mykhalchyshyn, N Molochek, O Savchuk, ... Obesity Medicine 19, 100248, 2020 | 38 | 2020 |
| Probiotics for experimental obesity prevention: focus on strain dependence and viability of composition N Kobyliak, T Falalyeyeva, T Beregova, M Spivak Endokrynologia Polska 68 (6), 659-667, 2017 | 37 | 2017 |
| Comparative experimental investigation on the efficacy of mono-and multiprobiotic strains in non-alcoholic fatty liver disease prevention N Kobyliak, T Falalyeyeva, O Virchenko, G Mykhalchyshyn, P Bodnar, ... BMC gastroenterology 16, 1-9, 2016 | 36 | 2016 |
| New insights on strain-specific impacts of probiotics on insulin resistance: evidence from animal study N Kobyliak, T Falalyeyeva, O Tsyryuk, M Eslami, D Kyriienko, T Beregova, ... Journal of Diabetes & Metabolic Disorders 19, 289-296, 2020 | 34 | 2020 |
| Probiotics and obesity associated disease: an extended view beyond traditional strains. T Falalyeyeva, Y Mamula, E Scarpellini, I Leshchenko, A Humeniuk, ... Minerva Gastroenterology 67 (4), 348-356, 2021 | 30 | 2021 |
| Current status and future therapeutic options for fecal microbiota transplantation S Tkach, A Dorofeyev, I Kuzenko, N Boyko, T Falalyeyeva, L Boccuto, ... Medicina 58 (1), 84, 2022 | 29 | 2022 |
